Cargando…

2354. Report at Your Own Risk! Diagnostic Stewardship of Clostridioides difficile PCR Results from Syndromic Diarrhea Panel and Implications for Patient Outcomes

BACKGROUND: We implemented a syndromic gastrointestinal pathogen panel (GIP) in May 2018, for rapid diagnosis of infectious diarrhea. GIP Clostridioides difficile polymerase chain reaction (PCR) results were suppressed due to concerns about oversensitivity. All positive (+) GIP and standard of care...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadskier Montagne, Francis G, Cowman, Kelsie, Guo, Yi, Bartash, Rachel, Szymczak, Wendy, Levi, Michael, Weston, Gregory, Nori, Priya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810404/
http://dx.doi.org/10.1093/ofid/ofz360.2032
_version_ 1783462245762596864
author Wadskier Montagne, Francis G
Cowman, Kelsie
Guo, Yi
Bartash, Rachel
Szymczak, Wendy
Levi, Michael
Weston, Gregory
Nori, Priya
author_facet Wadskier Montagne, Francis G
Cowman, Kelsie
Guo, Yi
Bartash, Rachel
Szymczak, Wendy
Levi, Michael
Weston, Gregory
Nori, Priya
author_sort Wadskier Montagne, Francis G
collection PubMed
description BACKGROUND: We implemented a syndromic gastrointestinal pathogen panel (GIP) in May 2018, for rapid diagnosis of infectious diarrhea. GIP Clostridioides difficile polymerase chain reaction (PCR) results were suppressed due to concerns about oversensitivity. All positive (+) GIP and standard of care (SOC) C. difficile results were reviewed to understand C. difficile epidemiology and clinical outcomes. METHODS: Between May and December 2018, an audit of all adult patients with C. difficile (+) GIP results was conducted. Stewardship team obtained daily GIP results, reviewed patient charts, recommended a confirmatory SOC test, isolation, and treatment as indicated. Patients were classified as true C. difficile infection (CDI) with diarrhea and toxin or PCR positivity (Figure 1). We also reviewed GIP (+)/SOC negative (−) tests, and GIP (−)/SOC (−) tests (control group). GIP (+) patients with no confirmatory SOC test were excluded from the analysis. A multivariable logistic regression model was used to compare CDI at 3 months among groups. RESULTS: We reviewed 274 patients with a GIP C. difficile (+) result (Table 1). Seventy-one (26%) had no SOC sent. Of positive SOCs, 45 patients (37%) were positive by toxin A/B enzyme immunoassay (EIA), and 77 (63%) by PCR only (Figure 2A). There were 2153 total SOC tests sent, of these 332 (15%) were positive; 130 (39%) by toxin, and 202 (61%) by PCR only (Figure 2B). Mortality and 30-day re-admission were not significantly different between groups (Table 2). CDI rates within 3 months were not significantly different between GIP (+) only and control group (P = 0.11). In contrast, those with SOC (+) tests had more true CDI within 3 months, compared with controls (P < 0.001) (Table 2). CONCLUSION: Forty percent of patients analyzed with GIP (+) C. difficile result were (−) by SOC test, suggesting that true CDI was not present in these patients. The percentage of toxin vs. PCR only (+) results from all the GIP positive patients mirrors that of all SOC (+) tests, indicating that the majority of CDI patients at our institution are PCR (+) only. Our results suggest that an additional PCR-based test may potentially over-report colonization as true infection. We strongly support diagnostic stewardship of C. difficile results within syndromic gastrointestinal panels. [Image: see text] [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810404
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68104042019-10-28 2354. Report at Your Own Risk! Diagnostic Stewardship of Clostridioides difficile PCR Results from Syndromic Diarrhea Panel and Implications for Patient Outcomes Wadskier Montagne, Francis G Cowman, Kelsie Guo, Yi Bartash, Rachel Szymczak, Wendy Levi, Michael Weston, Gregory Nori, Priya Open Forum Infect Dis Abstracts BACKGROUND: We implemented a syndromic gastrointestinal pathogen panel (GIP) in May 2018, for rapid diagnosis of infectious diarrhea. GIP Clostridioides difficile polymerase chain reaction (PCR) results were suppressed due to concerns about oversensitivity. All positive (+) GIP and standard of care (SOC) C. difficile results were reviewed to understand C. difficile epidemiology and clinical outcomes. METHODS: Between May and December 2018, an audit of all adult patients with C. difficile (+) GIP results was conducted. Stewardship team obtained daily GIP results, reviewed patient charts, recommended a confirmatory SOC test, isolation, and treatment as indicated. Patients were classified as true C. difficile infection (CDI) with diarrhea and toxin or PCR positivity (Figure 1). We also reviewed GIP (+)/SOC negative (−) tests, and GIP (−)/SOC (−) tests (control group). GIP (+) patients with no confirmatory SOC test were excluded from the analysis. A multivariable logistic regression model was used to compare CDI at 3 months among groups. RESULTS: We reviewed 274 patients with a GIP C. difficile (+) result (Table 1). Seventy-one (26%) had no SOC sent. Of positive SOCs, 45 patients (37%) were positive by toxin A/B enzyme immunoassay (EIA), and 77 (63%) by PCR only (Figure 2A). There were 2153 total SOC tests sent, of these 332 (15%) were positive; 130 (39%) by toxin, and 202 (61%) by PCR only (Figure 2B). Mortality and 30-day re-admission were not significantly different between groups (Table 2). CDI rates within 3 months were not significantly different between GIP (+) only and control group (P = 0.11). In contrast, those with SOC (+) tests had more true CDI within 3 months, compared with controls (P < 0.001) (Table 2). CONCLUSION: Forty percent of patients analyzed with GIP (+) C. difficile result were (−) by SOC test, suggesting that true CDI was not present in these patients. The percentage of toxin vs. PCR only (+) results from all the GIP positive patients mirrors that of all SOC (+) tests, indicating that the majority of CDI patients at our institution are PCR (+) only. Our results suggest that an additional PCR-based test may potentially over-report colonization as true infection. We strongly support diagnostic stewardship of C. difficile results within syndromic gastrointestinal panels. [Image: see text] [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810404/ http://dx.doi.org/10.1093/ofid/ofz360.2032 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Wadskier Montagne, Francis G
Cowman, Kelsie
Guo, Yi
Bartash, Rachel
Szymczak, Wendy
Levi, Michael
Weston, Gregory
Nori, Priya
2354. Report at Your Own Risk! Diagnostic Stewardship of Clostridioides difficile PCR Results from Syndromic Diarrhea Panel and Implications for Patient Outcomes
title 2354. Report at Your Own Risk! Diagnostic Stewardship of Clostridioides difficile PCR Results from Syndromic Diarrhea Panel and Implications for Patient Outcomes
title_full 2354. Report at Your Own Risk! Diagnostic Stewardship of Clostridioides difficile PCR Results from Syndromic Diarrhea Panel and Implications for Patient Outcomes
title_fullStr 2354. Report at Your Own Risk! Diagnostic Stewardship of Clostridioides difficile PCR Results from Syndromic Diarrhea Panel and Implications for Patient Outcomes
title_full_unstemmed 2354. Report at Your Own Risk! Diagnostic Stewardship of Clostridioides difficile PCR Results from Syndromic Diarrhea Panel and Implications for Patient Outcomes
title_short 2354. Report at Your Own Risk! Diagnostic Stewardship of Clostridioides difficile PCR Results from Syndromic Diarrhea Panel and Implications for Patient Outcomes
title_sort 2354. report at your own risk! diagnostic stewardship of clostridioides difficile pcr results from syndromic diarrhea panel and implications for patient outcomes
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810404/
http://dx.doi.org/10.1093/ofid/ofz360.2032
work_keys_str_mv AT wadskiermontagnefrancisg 2354reportatyourownriskdiagnosticstewardshipofclostridioidesdifficilepcrresultsfromsyndromicdiarrheapanelandimplicationsforpatientoutcomes
AT cowmankelsie 2354reportatyourownriskdiagnosticstewardshipofclostridioidesdifficilepcrresultsfromsyndromicdiarrheapanelandimplicationsforpatientoutcomes
AT guoyi 2354reportatyourownriskdiagnosticstewardshipofclostridioidesdifficilepcrresultsfromsyndromicdiarrheapanelandimplicationsforpatientoutcomes
AT bartashrachel 2354reportatyourownriskdiagnosticstewardshipofclostridioidesdifficilepcrresultsfromsyndromicdiarrheapanelandimplicationsforpatientoutcomes
AT szymczakwendy 2354reportatyourownriskdiagnosticstewardshipofclostridioidesdifficilepcrresultsfromsyndromicdiarrheapanelandimplicationsforpatientoutcomes
AT levimichael 2354reportatyourownriskdiagnosticstewardshipofclostridioidesdifficilepcrresultsfromsyndromicdiarrheapanelandimplicationsforpatientoutcomes
AT westongregory 2354reportatyourownriskdiagnosticstewardshipofclostridioidesdifficilepcrresultsfromsyndromicdiarrheapanelandimplicationsforpatientoutcomes
AT noripriya 2354reportatyourownriskdiagnosticstewardshipofclostridioidesdifficilepcrresultsfromsyndromicdiarrheapanelandimplicationsforpatientoutcomes